Covid-19 Impact on Global CRISPR Genome Editing Market Size, Status and Forecast 2020-2026

Covid-19 Impact on Global CRISPR Genome Editing Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by CRISPR Genome Editing Revenue
1.4 Market Analysis by Type
1.4.1 Global CRISPR Genome Editing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Genetic Engineering
1.4.3 Gene Library
1.4.4 Human Stem Cells
1.4.5 Others
1.5 Market by Application
1.5.1 Global CRISPR Genome Editing Market Share by Application: 2020 VS 2026
1.5.2 Biotechnology Companies
1.5.3 Pharmaceutical Companies
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): CRISPR Genome Editing Industry Impact
1.6.1 How the Covid-19 is Affecting the CRISPR Genome Editing Industry
1.6.1.1 CRISPR Genome Editing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and CRISPR Genome Editing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for CRISPR Genome Editing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 CRISPR Genome Editing Market Perspective (2015-2026)
2.2 CRISPR Genome Editing Growth Trends by Regions
2.2.1 CRISPR Genome Editing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 CRISPR Genome Editing Historic Market Share by Regions (2015-2020)
2.2.3 CRISPR Genome Editing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 CRISPR Genome Editing Market Growth Strategy
2.3.6 Primary Interviews with Key CRISPR Genome Editing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top CRISPR Genome Editing Players by Market Size
3.1.1 Global Top CRISPR Genome Editing Players by Revenue (2015-2020)
3.1.2 Global CRISPR Genome Editing Revenue Market Share by Players (2015-2020)
3.1.3 Global CRISPR Genome Editing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global CRISPR Genome Editing Market Concentration Ratio
3.2.1 Global CRISPR Genome Editing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by CRISPR Genome Editing Revenue in 2019
3.3 CRISPR Genome Editing Key Players Head office and Area Served
3.4 Key Players CRISPR Genome Editing Product Solution and Service
3.5 Date of Enter into CRISPR Genome Editing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global CRISPR Genome Editing Historic Market Size by Type (2015-2020)
4.2 Global CRISPR Genome Editing Forecasted Market Size by Type (2021-2026)
5 CRISPR Genome Editing Breakdown Data by Application (2015-2026)
5.1 Global CRISPR Genome Editing Market Size by Application (2015-2020)
5.2 Global CRISPR Genome Editing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America CRISPR Genome Editing Market Size (2015-2020)
6.2 CRISPR Genome Editing Key Players in North America (2019-2020)
6.3 North America CRISPR Genome Editing Market Size by Type (2015-2020)
6.4 North America CRISPR Genome Editing Market Size by Application (2015-2020)
7 Europe
7.1 Europe CRISPR Genome Editing Market Size (2015-2020)
7.2 CRISPR Genome Editing Key Players in Europe (2019-2020)
7.3 Europe CRISPR Genome Editing Market Size by Type (2015-2020)
7.4 Europe CRISPR Genome Editing Market Size by Application (2015-2020)
8 China
8.1 China CRISPR Genome Editing Market Size (2015-2020)
8.2 CRISPR Genome Editing Key Players in China (2019-2020)
8.3 China CRISPR Genome Editing Market Size by Type (2015-2020)
8.4 China CRISPR Genome Editing Market Size by Application (2015-2020)
9 Japan
9.1 Japan CRISPR Genome Editing Market Size (2015-2020)
9.2 CRISPR Genome Editing Key Players in Japan (2019-2020)
9.3 Japan CRISPR Genome Editing Market Size by Type (2015-2020)
9.4 Japan CRISPR Genome Editing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia CRISPR Genome Editing Market Size (2015-2020)
10.2 CRISPR Genome Editing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia CRISPR Genome Editing Market Size by Type (2015-2020)
10.4 Southeast Asia CRISPR Genome Editing Market Size by Application (2015-2020)
11 India
11.1 India CRISPR Genome Editing Market Size (2015-2020)
11.2 CRISPR Genome Editing Key Players in India (2019-2020)
11.3 India CRISPR Genome Editing Market Size by Type (2015-2020)
11.4 India CRISPR Genome Editing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America CRISPR Genome Editing Market Size (2015-2020)
12.2 CRISPR Genome Editing Key Players in Central & South America (2019-2020)
12.3 Central & South America CRISPR Genome Editing Market Size by Type (2015-2020)
12.4 Central & South America CRISPR Genome Editing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Editas Medicine
13.1.1 Editas Medicine Company Details
13.1.2 Editas Medicine Business Overview and Its Total Revenue
13.1.3 Editas Medicine CRISPR Genome Editing Introduction
13.1.4 Editas Medicine Revenue in CRISPR Genome Editing Business (2015-2020))
13.1.5 Editas Medicine Recent Development
13.2 CRISPR Therapeutics
13.2.1 CRISPR Therapeutics Company Details
13.2.2 CRISPR Therapeutics Business Overview and Its Total Revenue
13.2.3 CRISPR Therapeutics CRISPR Genome Editing Introduction
13.2.4 CRISPR Therapeutics Revenue in CRISPR Genome Editing Business (2015-2020)
13.2.5 CRISPR Therapeutics Recent Development
13.3 Horizon Discovery
13.3.1 Horizon Discovery Company Details
13.3.2 Horizon Discovery Business Overview and Its Total Revenue
13.3.3 Horizon Discovery CRISPR Genome Editing Introduction
13.3.4 Horizon Discovery Revenue in CRISPR Genome Editing Business (2015-2020)
13.3.5 Horizon Discovery Recent Development
13.4 Sigma-Aldrich
13.4.1 Sigma-Aldrich Company Details
13.4.2 Sigma-Aldrich Business Overview and Its Total Revenue
13.4.3 Sigma-Aldrich CRISPR Genome Editing Introduction
13.4.4 Sigma-Aldrich Revenue in CRISPR Genome Editing Business (2015-2020)
13.4.5 Sigma-Aldrich Recent Development
13.5 Genscript
13.5.1 Genscript Company Details
13.5.2 Genscript Business Overview and Its Total Revenue
13.5.3 Genscript CRISPR Genome Editing Introduction
13.5.4 Genscript Revenue in CRISPR Genome Editing Business (2015-2020)
13.5.5 Genscript Recent Development
13.6 Sangamo Biosciences
13.6.1 Sangamo Biosciences Company Details
13.6.2 Sangamo Biosciences Business Overview and Its Total Revenue
13.6.3 Sangamo Biosciences CRISPR Genome Editing Introduction
13.6.4 Sangamo Biosciences Revenue in CRISPR Genome Editing Business (2015-2020)
13.6.5 Sangamo Biosciences Recent Development
13.7 Lonza Group
13.7.1 Lonza Group Company Details
13.7.2 Lonza Group Business Overview and Its Total Revenue
13.7.3 Lonza Group CRISPR Genome Editing Introduction
13.7.4 Lonza Group Revenue in CRISPR Genome Editing Business (2015-2020)
13.7.5 Lonza Group Recent Development
13.8 Integrated DNA Technologies
13.8.1 Integrated DNA Technologies Company Details
13.8.2 Integrated DNA Technologies Business Overview and Its Total Revenue
13.8.3 Integrated DNA Technologies CRISPR Genome Editing Introduction
13.8.4 Integrated DNA Technologies Revenue in CRISPR Genome Editing Business (2015-2020)
13.8.5 Integrated DNA Technologies Recent Development
13.9 New England Biolabs
13.9.1 New England Biolabs Company Details
13.9.2 New England Biolabs Business Overview and Its Total Revenue
13.9.3 New England Biolabs CRISPR Genome Editing Introduction
13.9.4 New England Biolabs Revenue in CRISPR Genome Editing Business (2015-2020)
13.9.5 New England Biolabs Recent Development
13.10 Origene Technologies
13.10.1 Origene Technologies Company Details
13.10.2 Origene Technologies Business Overview and Its Total Revenue
13.10.3 Origene Technologies CRISPR Genome Editing Introduction
13.10.4 Origene Technologies Revenue in CRISPR Genome Editing Business (2015-2020)
13.10.5 Origene Technologies Recent Development
13.11 Transposagen Biopharmaceuticals
10.11.1 Transposagen Biopharmaceuticals Company Details
10.11.2 Transposagen Biopharmaceuticals Business Overview and Its Total Revenue
10.11.3 Transposagen Biopharmaceuticals CRISPR Genome Editing Introduction
10.11.4 Transposagen Biopharmaceuticals Revenue in CRISPR Genome Editing Business (2015-2020)
10.11.5 Transposagen Biopharmaceuticals Recent Development
13.12 Thermo Fisher Scientific
10.12.1 Thermo Fisher Scientific Company Details
10.12.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
10.12.3 Thermo Fisher Scientific CRISPR Genome Editing Introduction
10.12.4 Thermo Fisher Scientific Revenue in CRISPR Genome Editing Business (2015-2020)
10.12.5 Thermo Fisher Scientific Recent Development
13.13 Caribou Biosciences
10.13.1 Caribou Biosciences Company Details
10.13.2 Caribou Biosciences Business Overview and Its Total Revenue
10.13.3 Caribou Biosciences CRISPR Genome Editing Introduction
10.13.4 Caribou Biosciences Revenue in CRISPR Genome Editing Business (2015-2020)
10.13.5 Caribou Biosciences Recent Development
13.14 Precision Biosciences
10.14.1 Precision Biosciences Company Details
10.14.2 Precision Biosciences Business Overview and Its Total Revenue
10.14.3 Precision Biosciences CRISPR Genome Editing Introduction
10.14.4 Precision Biosciences Revenue in CRISPR Genome Editing Business (2015-2020)
10.14.5 Precision Biosciences Recent Development
13.15 Cellectis
10.15.1 Cellectis Company Details
10.15.2 Cellectis Business Overview and Its Total Revenue
10.15.3 Cellectis CRISPR Genome Editing Introduction
10.15.4 Cellectis Revenue in CRISPR Genome Editing Business (2015-2020)
10.15.5 Cellectis Recent Development
13.16 Intellia Therapeutics
10.16.1 Intellia Therapeutics Company Details
10.16.2 Intellia Therapeutics Business Overview and Its Total Revenue
10.16.3 Intellia Therapeutics CRISPR Genome Editing Introduction
10.16.4 Intellia Therapeutics Revenue in CRISPR Genome Editing Business (2015-2020)
10.16.5 Intellia Therapeutics Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. CRISPR Genome Editing Key Market Segments
Table 2. Key Players Covered: Ranking by CRISPR Genome Editing Revenue
Table 3. Ranking of Global Top CRISPR Genome Editing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global CRISPR Genome Editing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Genetic Engineering
Table 6. Key Players of Gene Library
Table 7. Key Players of Human Stem Cells
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four CRISPR Genome Editing Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for CRISPR Genome Editing Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for CRISPR Genome Editing Players to Combat Covid-19 Impact
Table 14. Global CRISPR Genome Editing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global CRISPR Genome Editing Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global CRISPR Genome Editing Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global CRISPR Genome Editing Market Share by Regions (2015-2020)
Table 18. Global CRISPR Genome Editing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global CRISPR Genome Editing Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. CRISPR Genome Editing Market Growth Strategy
Table 24. Main Points Interviewed from Key CRISPR Genome Editing Players
Table 25. Global CRISPR Genome Editing Revenue by Players (2015-2020) (Million US$)
Table 26. Global CRISPR Genome Editing Market Share by Players (2015-2020)
Table 27. Global Top CRISPR Genome Editing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR Genome Editing as of 2019)
Table 28. Global CRISPR Genome Editing by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players CRISPR Genome Editing Product Solution and Service
Table 31. Date of Enter into CRISPR Genome Editing Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 34. Global CRISPR Genome Editing Market Size Share by Type (2015-2020)
Table 35. Global CRISPR Genome Editing Revenue Market Share by Type (2021-2026)
Table 36. Global CRISPR Genome Editing Market Size Share by Application (2015-2020)
Table 37. Global CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 38. Global CRISPR Genome Editing Market Size Share by Application (2021-2026)
Table 39. North America Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 40. North America Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 41. North America CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 42. North America CRISPR Genome Editing Market Share by Type (2015-2020)
Table 43. North America CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 44. North America CRISPR Genome Editing Market Share by Application (2015-2020)
Table 45. Europe Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 47. Europe CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 48. Europe CRISPR Genome Editing Market Share by Type (2015-2020)
Table 49. Europe CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 50. Europe CRISPR Genome Editing Market Share by Application (2015-2020)
Table 51. China Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 52. China Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 53. China CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 54. China CRISPR Genome Editing Market Share by Type (2015-2020)
Table 55. China CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 56. China CRISPR Genome Editing Market Share by Application (2015-2020)
Table 57. Japan Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 59. Japan CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 60. Japan CRISPR Genome Editing Market Share by Type (2015-2020)
Table 61. Japan CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 62. Japan CRISPR Genome Editing Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 65. Southeast Asia CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia CRISPR Genome Editing Market Share by Type (2015-2020)
Table 67. Southeast Asia CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia CRISPR Genome Editing Market Share by Application (2015-2020)
Table 69. India Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 70. India Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 71. India CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 72. India CRISPR Genome Editing Market Share by Type (2015-2020)
Table 73. India CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 74. India CRISPR Genome Editing Market Share by Application (2015-2020)
Table 75. Central & South America Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 77. Central & South America CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America CRISPR Genome Editing Market Share by Type (2015-2020)
Table 79. Central & South America CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America CRISPR Genome Editing Market Share by Application (2015-2020)
Table 81. Editas Medicine Company Details
Table 82. Editas Medicine Business Overview
Table 83. Editas Medicine Product
Table 84. Editas Medicine Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 85. Editas Medicine Recent Development
Table 86. CRISPR Therapeutics Company Details
Table 87. CRISPR Therapeutics Business Overview
Table 88. CRISPR Therapeutics Product
Table 89. CRISPR Therapeutics Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 90. CRISPR Therapeutics Recent Development
Table 91. Horizon Discovery Company Details
Table 92. Horizon Discovery Business Overview
Table 93. Horizon Discovery Product
Table 94. Horizon Discovery Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 95. Horizon Discovery Recent Development
Table 96. Sigma-Aldrich Company Details
Table 97. Sigma-Aldrich Business Overview
Table 98. Sigma-Aldrich Product
Table 99. Sigma-Aldrich Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 100. Sigma-Aldrich Recent Development
Table 101. Genscript Company Details
Table 102. Genscript Business Overview
Table 103. Genscript Product
Table 104. Genscript Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 105. Genscript Recent Development
Table 106. Sangamo Biosciences Company Details
Table 107. Sangamo Biosciences Business Overview
Table 108. Sangamo Biosciences Product
Table 109. Sangamo Biosciences Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 110. Sangamo Biosciences Recent Development
Table 111. Lonza Group Company Details
Table 112. Lonza Group Business Overview
Table 113. Lonza Group Product
Table 114. Lonza Group Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 115. Lonza Group Recent Development
Table 116. Integrated DNA Technologies Business Overview
Table 117. Integrated DNA Technologies Product
Table 118. Integrated DNA Technologies Company Details
Table 119. Integrated DNA Technologies Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 120. Integrated DNA Technologies Recent Development
Table 121. New England Biolabs Company Details
Table 122. New England Biolabs Business Overview
Table 123. New England Biolabs Product
Table 124. New England Biolabs Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 125. New England Biolabs Recent Development
Table 126. Origene Technologies Company Details
Table 127. Origene Technologies Business Overview
Table 128. Origene Technologies Product
Table 129. Origene Technologies Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 130. Origene Technologies Recent Development
Table 131. Transposagen Biopharmaceuticals Company Details
Table 132. Transposagen Biopharmaceuticals Business Overview
Table 133. Transposagen Biopharmaceuticals Product
Table 134. Transposagen Biopharmaceuticals Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 135. Transposagen Biopharmaceuticals Recent Development
Table 136. Thermo Fisher Scientific Company Details
Table 137. Thermo Fisher Scientific Business Overview
Table 138. Thermo Fisher Scientific Product
Table 139. Thermo Fisher Scientific Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 140. Thermo Fisher Scientific Recent Development
Table 141. Caribou Biosciences Company Details
Table 142. Caribou Biosciences Business Overview
Table 143. Caribou Biosciences Product
Table 144. Caribou Biosciences Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 145. Caribou Biosciences Recent Development
Table 146. Precision Biosciences Company Details
Table 147. Precision Biosciences Business Overview
Table 148. Precision Biosciences Product
Table 149. Precision Biosciences Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 150. Precision Biosciences Recent Development
Table 151. Cellectis Company Details
Table 152. Cellectis Business Overview
Table 153. Cellectis Product
Table 154. Cellectis Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 155. Cellectis Recent Development
Table 156. Intellia Therapeutics Company Details
Table 157. Intellia Therapeutics Business Overview
Table 158. Intellia Therapeutics Product
Table 159. Intellia Therapeutics Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 160. Intellia Therapeutics Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR Genome Editing Market Share by Type: 2020 VS 2026
Figure 2. Genetic Engineering Features
Figure 3. Gene Library Features
Figure 4. Human Stem Cells Features
Figure 5. Others Features
Figure 6. Global CRISPR Genome Editing Market Share by Application: 2020 VS 2026
Figure 7. Biotechnology Companies Case Studies
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Others Case Studies
Figure 10. CRISPR Genome Editing Report Years Considered
Figure 11. Global CRISPR Genome Editing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global CRISPR Genome Editing Market Share by Regions: 2020 VS 2026
Figure 13. Global CRISPR Genome Editing Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global CRISPR Genome Editing Market Share by Players in 2019
Figure 16. Global Top CRISPR Genome Editing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR Genome Editing as of 2019
Figure 17. The Top 10 and 5 Players Market Share by CRISPR Genome Editing Revenue in 2019
Figure 18. North America CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Editas Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Editas Medicine Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 27. CRISPR Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. CRISPR Therapeutics Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 29. Horizon Discovery Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Horizon Discovery Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 31. Sigma-Aldrich Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Sigma-Aldrich Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 33. Genscript Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Genscript Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 35. Sangamo Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Sangamo Biosciences Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 37. Lonza Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Lonza Group Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 39. Integrated DNA Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Integrated DNA Technologies Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 41. New England Biolabs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. New England Biolabs Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 43. Origene Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Origene Technologies Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 45. Transposagen Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Transposagen Biopharmaceuticals Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 47. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 49. Caribou Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Caribou Biosciences Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 51. Precision Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Precision Biosciences Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 53. Cellectis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Cellectis Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 55. Intellia Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Intellia Therapeutics Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs